Previously studies have shown that compounds such as curcumin and zerumbone exhibited anti-lymphoma activity via NF-κB inhibition and mitochondrial-mediated apoptosis through upregulation of pro-apoptotic proteins and suppression of c-Myc in Burkitt’s lymphoma cells [8,9]. This evidence concerns the gene MYC and lymphoma.